drolysis of the synthetic peptides for amino acid analysis was performed by reacting with 6 M HCl vapor at 130°C for 3 h in the same manner as reported previously. 5) The amino acid analysis data of various synthetic peptides is shown in Table 1 , while their FAB-MS analysis data and characteristics are shown in Table 2 .
Stability Test The peptide solutions related to porcine neuromedin U-8 were prepared under ice cooling at a concentrations of 4ϫ10 Ϫ4 M in a) Tyrode's solution (pH 7.4) of the following composition (mM): NaCl 137, KCl 2.7, CaCl 2 1.8, MgCl 2 1.1, NaH 2 PO 4 0.4, NaHCO 3 12, D-glucose 5.6, b) 0.1 M NaHCO 3 , c) 2% NH 4 OH (ammonia solution), or d) 1 M HCl. The peptide solutions related to VIP were prepared at a concentration of 4ϫ10
To examine the decomposition reaction, these peptide solutions were divided into ten aliquots (100 ml each) in polypropylene tubes (2 ml), which were tightly capped and kept at 60°C (or exceptionally at 4°C, for peptide solutions in 2% NH 4 OH) in a thermostatically regulated apparatus. Samples were removed from the apparatus at an appropriate time (shown in Figs. 2- 6), neutralized under ice cooling and kept in a freezer at Ϫ40°C until analysis. RP-HPLC employing a J'sphere ODS H-80 (4.6ϫ250 mm, YMC Co., Japan) column was used for quantitative analysis, where the peak area at a wavelength of 210 nm was integrated. The decomposition products isolated from HPLC peaks were assigned by amino acid analysis and FAB-MS, and the structure was confirmed by co-elution on HPLC with authentic synthetic peptides. Biological Activity of Neuromedin U-8 Analogs The biological activity of synthetic peptides was evaluated by a contraction assay on a chicken crop smooth muscle preparation as described in a previous paper. 6) Briefly, a strip of smooth muscle from the chicken crop was mounted longitudinally at a resting tension of 0.5 g in an organ bath (10 ml) containing Tyrode's solution at 30°C. The tissue preparation was equilibrated for 60 min, and was then challenged twice with carbachol (2ϫ10 Ϫ6 M), and once with X-Asn-NH 2 (1) added cumulatively up to 3ϫ10 Ϫ6 M. After re-equilibration for 30-40 min, increasing concentrations of 1 were added up to 3ϫ10
Ϫ6 M, and after a 30 min resting period by those of an analog (2, 3, or 4) up to 3ϫ10
The pharmacological parameters, RA value (relative activity; EC 50 of 1/EC 50 of an analog), maximum contraction (efficacy; %) [(maximum effect induced by 3ϫ10 Ϫ6 M of an analog/maximum effect induced by 3ϫ10 Ϫ6 M of 1)ϫ100] were calculated from the cumulative concentration-response curves. These experiments were repeated 5 to 7 times.
Immunochemical Reactivity of Neuromedin U Analogs Neuromedin U radioimmunoassay (RIA) system was established in the same manner as reported previously. 12) Briefly, an anti-neuromedin U-8 antiserum (ASH-15) was obtained from a rabbit after ninth subcutaneous injection of bovine serum albumin (BSA)-conjugate of 1 at the N-terminal Tyr, and used for RIA at a final dilution of 30000. Iodination of 1 was carried out with 125 I Na by 1,3,4,6-tetrachloro-3a,6a-diphenyl-glycouril (Pierce Co., U.S.A.) and the labeled antigen was purified by RP-HPLC. Separation of free and bound tracers was performed by the dextran-charcoal method.
Results and Discussion
Stability of Porcine Neuromedin U-8 (1) in Tyrode's Solution at 60°C and in 2% Ammonia Solution at 4°C The RP-HPLC chromatogram shown in Fig. 2A represents the decomposition mixture of porcine neuromedin U-8 (XAsn-NH 2 , 1) in Tyrode's solution (pH 7.4) at an elevated temperature of 60°C. The separation of the decomposition products was attained by RP-HPLC with an isocratic elution of 19% acetonitrile in 0.1% trifluoroacetic acid (TFA) at a low flow rate (0.6 ml/min). The peaks 2 and 3 were analyzed as the partially hydrolyzed peptides of X-Asn-NH 2 either at the a-amide or at the b-amide, since these peaks co-eluted with authentic synthetic peptides, X-Asn-OH (2) and X-Asp-NH 2 (3), respectively. The size of a small-unknown product peak 4 increased in the first 2-3 h, then decreased, and almost completely disappeared in 10 h.
The degradation and accumulation curves of X-Asn-NH 2 (1, peak 1), X-Asn-OH (2, peak 2) and X-Asp-NH 2 (3, peak 3) are shown in Fig. 2B . The half-life period (t 1/2 ) of X-Asn-NH 2 (1) was 3.6 h, and the molar ratio of the products XAsn-OH (2) and X-Asp-NH 2 (3) was about 4.5 to 1.
The degradation products of peaks 2, 3, and 4 were isolated by RP-HPLC. Peak 4 was assumed to be the aminosuccinimide form (X-Asu, MW C 54 H 75 N 15 It was observed that the incubation of X-Asn-NH 2 in a 2% ammonia solution at 4°C led to a greatly increased amount of the unknown product peak 4 (Figs. 2C, D) . The time courses for X-Asn-NH 2 (1) and its decomposition products in cold ammonia solution show that the t 1/2 of X-Asn-NH 2 (1) is 15 h, and that X-Asu was considerably stable under these conditions. The molar ratio of X-Asn-OH (2) and X-Asp-NH 2 (3) was about 4.5 to1.
Stability of Porcine Neuromedin U-8 in 0.1 M NaHCO 3 at 60°C The decomposition reaction of porcine neuromedin U-8 (X-Asn-NH 2 , 1) was examined in a 0.1 M NaHCO 3 solution at 60°C. As seen from the degradation curves in Fig. 3 , the reaction proceeded faster than in Tyrode's solution at the same temperature. The half-life period (t 1/2 ) of X-Asn-NH 2 (1) was 1.5 h. The ratio of the degradation products, X-Asn-OH (2) and X-Asp-NH 2 (3) was again at about 4.5 to 1 (data not shown). When X-Asu, isolated from peak 4 in the reaction mixture of X-Asn-NH 2 (1) in 2% NH 4 OH as described above, was kept in 0.1 M NaHCO 3 at 60°C, the degradation reaction proceeded very fast. The t 1/2 of X-Asu was around 0.3 h, producing X-Asn-OH (2) and XAsp-NH 2 (3) in a ratio of about 4.5 to 1. These results confirm that the peak 4 observed in Fig. 2C was the succinimide form. Due to the difficulty associated with separation of octapeptides 1-4 by HPLC (Figs. 2A, C) in time course data experiments, smaller model peptides were used for further 
study.
Stability of Model Tripeptide Amides in 0.1 M NaHCO 3 at 60°C In order to simplify the HPLC analysis, a model tripeptide (Y-Asn-NH 2 , 5, YϭBenzoyl-Pro-Arg), related to porcine neuromedin U-8, and its analogs were synthesized and used for the stability test. Y-Asn-NH 2 (5) decomposed almost as fast as X-Asn-NH 2 (1) in 0.1 M NaHCO 3 at 60°C with the t 1/2 of 1.9 h (Fig. 3 and Table 3 ). On the other hand, Y-Gly-NH 2 (9) and Y-Gln-NH 2 (10) survived to a level of more than 90% after 2.5 h (Fig. 3 ).
In the case of H-Ile-Leu-Asn-NH 2 (16), a model tripeptide amide related to the C-terminal of VIP, minor peaks of the decomposition products were examined in detail. The peaks 1-6 that appeared in the incubation solution of H-Ile-LeuAsn-NH 2 (16) in 0.1 M NaHCO 3 at 60°C (Fig. 4A) were isolated and analyzed by FAB-MS to deduce their structures, which were confirmed by co-elution with authentic synthetic peptides. In independent experiments, the synthetic peptides, H-Ile-Leu-D-Asn-OH (20) , H-Ile-Leu-Asn-NH 2 (16), H-IleLeu-Asn-OH (17), H-Ile-Leu-Asp-NH 2 (18) , and H-Ile-Leu-D-Asp-NH 2 (21), co-eluted with peaks 1, 2, 3, 4, and 5, respectively. FAB-MS analysis of the isolated material from peak 6 showed the molecular ion of 341, which corresponded to H-Ile-Leu-Asu. Thus, the partial epimerization of H-IleLeu-Asu occurred in mild alkaline solution to produce the Cterminal D-Asn and D-Asp peptides (20, 21) .
The time courses of these peptides are shown in Fig. 4B . H-Ile-Leu-Asn-NH 2 (16) had decomposed by more than 40% after 2.5 h (the t 1/2 was 2.8 h, Fig. 4B ). These results suggest that the C-terminal Asn-NH 2 portions of both neuromedin U-8 and VIP have higher susceptibility to alkaline solution than the other C-terminal amides, Gly-NH 2 , and Gln-NH 2 .
Comparative Stability Experiment with Model AsnGly-and Asn-Ser-Peptides in 0.1 M NaHCO 3 at 60°C A model pentapeptide Y-Asn-Gly-Ala-OH (YϭBenzoyl-ProArg, 11), which is known to contain a structure involved in formation of a succinimide derivative formation, decomposed rapidly to yield Y-Asp-Gly-Ala-OH (14) (12, 13) , the model tripeptide amides (5, 9, 10, 16) , and porcine neuromedin U-8 (1) are summarized in Table 3 . It is clear that the peptides bearing the C-terminal Asn-NH 2 (1, 5, and 16 with t 1/2 values of 1.5, 1.9, and 2.8 h, respectively) have higher susceptibility than Y-Asn-Ser-Ala-OH (12, t 1/2 ϭ5.1 h) or Y-Asn-Ala-Ala-OH (13, t 1/2 ϭ6.8 h), and higher stability than Y-Asn-Gly-Ala-OH (11, t 1/2 0.5 h) in 0.1 M NaHCO 3 at 60°C.
The (5) 1.9 1.6 Y-Gly-NH 2 (9) -
0.8 Y-Asn-Gly-Ala-OH (11) 0.5 2.7 Y-Asn-Ser-Ala-OH (12) 5.1 3.0 Y-Asn-Ala-Ala-OH (13) 6.8
XϭH-Tyr-Phe-Leu-Phe-Arg-Pro-Arg, YϭBenzoyl-Pro-Arg. a) t 1/2 Ͼ Ͼ3 h (see Fig. 3 ). (11) decreased under these conditions to yield a single product, Y-Asp-Gly-Ala-OH (14) . As shown in Table 3 , the degradation rates of the model pentapeptides YAsn-Gly-Ala-OH (11), Y-Asn-Ser-Ala-OH (12) and Y-AsnAla-Ala-OH (13), were similar with t 1/2 values of 2.7-3.0 h, while the t 1/2 of Y-Asn-NH 2 (5) was 1.9 h. These Asncontaining peptides were more stable than Y-Gly-NH 2 (9, t 1/2 ϭ1.1 h) and Y-Gln-NH 2 (10, t 1/2 ϭ0.8 h). The t 1/2 of neuromedin U-8 (1) was 1.3 h.
Smooth Muscle Contractile Activity and Immunochemical Cross-Reactivity of C-Terminally Deamidated Analogs of Porcine Neuromedin U-8
The biological activity of the deamidated peptides X-Asn-OH (2), X-Asp-NH 2 (3), and X-Asp-OH (4) was evaluated by chicken crop smooth muscle contraction assay. The deamidation products of the a-carboxamide (2, 4) underwent a complete loss of the biological activity. X-Asp-NH 2 (3) retained a weak biological activity but the dose-response curves shifted to the right, and the maximum contractile response elicited at 3ϫ10
Ϫ6 M was 80% of X-Asn-NH 2 (1) (Fig. 7) .
It was found that the neuromedin U-8 RIA system employing the antiserum ASH-15 was C-terminal specific, because the synthetic N-terminal analogs such as porcine neuromedin U-25 1, 13) (Fig. 8 ) displaced the tracer,
125
I-X-Asn-NH 2 , in the same manner as X-Asn-NH 2 (1). The same result was obtained for rat neuromedin U-23, 5, 14, 15) dog neuromedin U-8 bearing pGlu at the N-terminal, 6, 16) and [Gly 1 ]-neuromedin U-8, 17) (data not shown). The displacement curves of synthetic N-terminally deleted analogs 5) such as H-Phe-LeuPhe-Arg-Pro-Arg-Asn-NH 2 , H-Leu-Phe-Arg-Pro-Arg-Asn-NH 2 , and H-Phe-Arg-Pro-Arg-Asn-NH 2 showed reduced but considerable cross-reactivity. The C-terminally deleted analogs H-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-OH 6) and [Gly 8 ]-neuromedin U-8 17) showed no activity in displacing the tracer. In this neuromedin U RIA system, the deamidation products 2, 3, and 4 had no cross-reactivity.
The RP-HPLC examination of the reaction mixture of XAsn-NH 2 (1) after standing in Tyrode's solution verified that the main decomposed products were X-Asn-OH (2) and Asp-NH 2 (3) . No peak corresponding to X-Asp-OH (4) appeared, however, a small peak corresponding to a succinimide intermediate derivative (X-Asu) was observed. This intermediate appeared as a major product after 24 h incubation in a cold diluted ammonia solution (Fig. 2) , where the conversion of X-Asu to X-Asn-OH (2) and X-Asp-NH 2 (3) was slower, but the ratio (4.5 : 1) of the monocarboxylic derivatives after 60 h was the same as in Tyrode's or 0.1 M NaHCO 3 solution. The mechanism was considered to proceed through succinimide formation, with spontaneous hydrolysis promoting the degradation of neuromedin U and VIP-related peptides, specifically at their C-terminal Asn-NH 2 portions. The model peptides bearing the C-terminal Gln-NH 2 and Gly-NH 2 were considerably stable in a weak alkaline solution. Thus, glutarimide formation from peptidyl-Gln-NH 2 seemed to occur very slowly, in the same manner as previously reported for a synthetic pentapeptide. 18) A model tripeptide amide related to VIP (H-Ile-Leu-Asn-NH 2 , 16) was much more stable than a model peptide related to neuromedin U-8 (Benzoyl-Arg-ProAsn-NH 2 , 5). These results suggest that the stability of the Cterminal Asn-NH 2 portion was somewhat dependent on the preceding sequence of the Asn residue. Although the deamidation of Asn-Gly or Asn-Ser peptides via succinimide intermediates has previously been studied in detail, [19] [20] [21] [22] the present results demonstrate that the degradation of the C-terminal Asn-NH 2 occurred faster than that of Asn-Ser and slower than that of Asn-Gly in 0.1 M NaHCO 3 . Further examination employing H-Ile-Leu-Asn-NH 2 suggest that the degradation of Asn-NH 2 through Asu formation was accompanied by racemization, as has previously been reported for a synthetic L-Asn-Gly peptide. 23) In a 1 M HCl solution at 60°C, the first deamidation of YAsn-NH 2 (5) produced a-and b-monocarboxylic acids (YAsn-OH, 6 and Y-Asp-NH 2 , 7), which decreased after 3 h due to a second hydrolysis that brought about an increase in the dicarboxylic acid (Y-Asp-OH, 8). Y-Asn-Gly-Ala-OH (11), the most susceptible peptide in a weak alkaline solution, was more stable than the three C-terminal amide peptides, Y-Asn-NH 2 (5), Y-Gly-NH 2 (9) , and Y-Gln-NH 2 (10) , in this mild acidic solution (Table 3) . Mild acid hydrolysis of Y-Asn-GlyAla-OH (11) produced exclusively Y-Asp-Gly-Ala-OH (14) , and no peak related to Y-Asp(b-Gly-Ala-OH)-OH (15) appeared on the HPLC chromatogram of the hydrolysate (data not shown). This result is in good agreement with that by Patel and Borchardt. 21) Thus, it can be concluded that the hydrolysis of C-terminal Asn-NH 2 in 1 M HCl proceeded independently at the a-and b-amides through an alternative pathway than alkaline hydrolysis.
The present study indicated that the C-terminal asparagine amide portions of neuromedin U and VIP were exceptionally The decomposition mechanism involved formation of succinimide intermediates followed by spontaneous hydrolysis (Fig. 9) , in a pathway similar to the deamidation of Asn-Gly or Asn-Ser peptides. The degradation of the C-terminal Asn-NH 2 occurred faster than that of Asn-Ser but slower than that of Asn-Gly in a weak alkaline solution. Acid hydrolysis of the C-terminal Asn-NH 2 in 1 M HCl proceeded faster than that of the internal peptide bonds to a similar extent to the other primary amides to yield Asn-OH and Asp-NH 2 peptides, both of which were converted into the C-terminal Asp-OH peptides. As the deamidation at the C-terminal of neuromedin U peptides brought about a great loss in the biological and immunochemical binding activities, the chemical characteristics of neuromedin U peptides with respect to the C-terminal Asn-NH 2 structure should be kept in mind in the handling of their solutions during biological and immunological study.
